# Hypertension Initial Visit Template

**Guideline References:** ACC/AHA 2017 Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults; AHA/ACC 2023 Update.

---

## Subjective

### Chief Complaint
- [ ] Elevated blood pressure / hypertension

### History of Present Illness
- Duration of hypertension: ______
- Previous blood pressure readings: ______
- Prior antihypertensive treatments: ______
- Symptoms suggesting secondary causes (palpitations, sweating, muscle weakness, headaches, visual changes): ______

### Past Medical History
- [ ] Diabetes mellitus
- [ ] Chronic kidney disease
- [ ] Cardiovascular disease (CAD, CHF, stroke)
- [ ] Hyperlipidemia
- [ ] Obesity (BMI ≥30)
- [ ] Obstructive sleep apnea

### Medication History
- Current antihypertensives: ______
- Adherence: [ ] Good [ ] Partial [ ] Poor
- Side effects: ______

### Family History
- Hypertension: [ ] Yes [ ] No
- Premature CVD (<55 male, <65 female): [ ] Yes [ ] No
- Stroke: [ ] Yes [ ] No
- Renal disease: [ ] Yes [ ] No

### Social History
- Tobacco use: [ ] Current [ ] Former [ ] Never
- Alcohol intake: ______ drinks/week
- Diet: Sodium intake (estimated): ______ mg/day; Fruits/vegetables servings: ______
- Physical activity: ______ minutes/week of moderate‑intensity
- Stress level: [ ] Low [ ] Moderate [ ] High

### Review of Systems
- Cardiovascular: chest pain, dyspnea, orthopnea, PND, edema
- Neurological: headache, dizziness, syncope, visual changes
- Renal: polyuria, nocturia, hematuria
- Endocrine: heat intolerance, weight changes, palpitations

---

## Objective

### Vital Signs
- Blood pressure (seated, right arm): ______ / ______ mmHg
- Blood pressure (seated, left arm): ______ / ______ mmHg
- Heart rate: ______ bpm
- Height: ______ cm/in
- Weight: ______ kg/lb
- BMI: ______ kg/m²
- Waist circumference: ______ cm/in

### Physical Exam
- Fundoscopic exam: [ ] Normal [ ] Arteriolar narrowing [ ] AV nicking [ ] Hemorrhages/exudates
- Carotid bruits: [ ] Present [ ] Absent
- Cardiac auscultation: [ ] Normal [ ] S4 gallop [ ] Murmur (describe): ______
- Abdominal bruits: [ ] Present [ ] Absent
- Peripheral pulses: [ ] Normal [ ] Diminished
- Edema: [ ] None [ ] 1+ [ ] 2+ [ ] 3+ [ ] 4+
- Neurologic exam: [ ] Normal [ ] Focal deficits

### Laboratory Data (check if available)
- Basic metabolic panel: Na ______, K ______, Cr ______, eGFR ______
- Lipid panel: Total chol ______, LDL ______, HDL ______, TG ______
- Urinalysis: Protein ______, Blood ______, Glucose ______
- ECG: [ ] Normal [ ] LVH [ ] Other: ______
- Echocardiography (if indicated): LVH present? [ ] Yes [ ] No; LVEF ______%

### Cardiovascular Risk Assessment
- ASCVD risk score: ______ % (10‑year risk)
  - Inputs: Age ______, Gender [ ] Male [ ] Female, Total chol ______, HDL ______, Systolic BP ______, Diabetes [ ] Yes [ ] No, Smoking [ ] Yes [ ] No, Treated for hypertension [ ] Yes [ ] No

---

## Assessment

### Diagnosis
- [ ] Primary (essential) hypertension
- [ ] Secondary hypertension suspected (workup indicated)
  - Possible causes: renal artery stenosis, primary aldosteronism, pheochromocytoma, etc.

### Stage of Hypertension (ACC/AHA)
- [ ] Normal (<120/<80 mmHg)
- [ ] Elevated (120‑129/<80 mmHg)
- [ ] Stage 1 (130‑139/80‑89 mmHg)
- [ ] Stage 2 (≥140/≥90 mmHg)

### Cardiovascular Risk Stratification
- [ ] Low risk (Stage 1, no ASCVD risk factors, no target organ damage)
- [ ] Intermediate risk (Stage 1 with risk factors, or Stage 2 with no risk factors)
- [ ] High risk (Stage 2 with risk factors, diabetes, CKD, or established ASCVD)
- [ ] Very high risk (Stage 2 with multiple comorbidities, target organ damage)

### Problem List
1. Hypertension
2. ______
3. ______

---

## Plan

### Lifestyle Modifications
- [ ] DASH diet counseling provided
- [ ] Sodium restriction (<2.3 g/day) discussed
- [ ] Increase dietary potassium (fruits, vegetables)
- [ ] Physical activity goal: ≥150 minutes moderate‑intensity per week
- [ ] Weight loss target: ______ kg (if overweight/obese)
- [ ] Smoking cessation resources offered
- [ ] Alcohol moderation (≤1 drink/day women, ≤2 drinks/day men)

### Pharmacologic Therapy
- First‑line agent selection (choose one or combination):
  - [ ] Thiazide‑type diuretic (e.g., chlorthalidone, HCTZ)
  - [ ] ACE inhibitor
  - [ ] ARB
  - [ ] Calcium channel blocker (dihydropyridine)
- Special considerations:
  - CKD: [ ] ACE‑i or ARB preferred
  - Black patients: [ ] Thiazide or CCB preferred
- Dose: ______
- Instructions: ______

### Monitoring
- Home blood pressure monitoring: [ ] Recommended; log provided
- Follow‑up interval: [ ] 1 month (Stage 2) [ ] 3‑6 months (Stage 1)
- Lab monitoring: Repeat BMP, lipid panel in ______ months
- ECG/echo follow‑up if indicated: ______

### Patient Education
- Hypertension education handout provided
- Medication adherence strategies discussed
- Recognition of hypertensive urgency/emergency symptoms reviewed
- Shared decision‑making documented: patient preferences incorporated

### Referrals
- [ ] Cardiology (resistant hypertension, suspected secondary cause)
- [ ] Nutritionist/dietician
- [ ] Smoking cessation program
- [ ] Exercise physiologist
- [ ] Other: ______

### Follow‑up Appointment
- Date: ______
- Planned actions: ______

---

*Template version: 1.0.0*  
*Last updated: 2025‑12‑28*  
*Contributors: [Your Name]*